Atalaya Capital Management’s Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock ARCK Stock Holding History

Atalaya Capital Management’s Portfolio ARCK Stock Details ARCK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-261,895	Closed	-$2.66M	–	326
2022 Q3	$2.66M	Buy	+261,895	New	+$2.64M	0.36%	73

Other funds holding ARCK

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Atalaya Capital Management's ARCK Position: Q4 2022 in Review

Atalaya Capital Management sold out of Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock (ARCK) in Q4 2022, closing a stake of 261,895 shares — an estimated $2.66M sold.

Atalaya Capital Management first reported a position in ARCK in Q3 2022 and held it in 1 quarter. The position peaked at $2.66M in Q3 2022. 2 funds tracked by Wall St. Rank hold ARCK as of Q4 2022.

Atalaya Capital Management reported no remaining Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock position as of Q4 2022 after selling out during the quarter.
Atalaya Capital Management sold 261,895 Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock shares in Q4 2022, an estimated $2.66M.
Atalaya Capital Management first reported a position in Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock in Q3 2022 and held it in 1 quarter.
Atalaya Capital Management's Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock position peaked at $2.66M in Q3 2022.
2 funds tracked by Wall St. Rank held Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock as of Q4 2022.

Based on Atalaya Capital Management's 13F filing for Q4 2022, filed 9 Feb 2023.